Related Experiment Video
Updated: Feb 7, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Correlation Between Serum GDF11 Levels and the Progression of Ischemic Mitral Regurgitation and Long-term Prognosis
Jiangping Ye1,2, Kewei Zong3, Yehong Liu2
1The Second People's Hospital of Changzhou, The Third Affiliated Hospital of Nanjing Medical University, Changzhou, Jiangsu, People's Republic of China.
Abstract:
Ischemic mitral regurgitation (IMR) commonly complicates pPCI in STEMI patients. GDF11, a protective cardiovascular factor, may influence IMR progression and prognosis. Among 310 STEMI patients, 126 with recent normal echocardiography underwent pPCI with pre-procedural GDF11 testing. Cox regression, ROC analysis, and Spearman's correlation assessed GDF11's predictive value for IMR exacerbation and cardiac function. Lower GDF11 predicted IMR worsening (HR = 0.982, P = 0.004; AUC = 0.744, P < 0.001). High GDF11 patients had reduced IMR progression (P = 0.0013) and heart failure risk (P = 0.0003). GDF11 correlated with LVEF and left atrial changes (P < 0.05). Serum GDF11 independently predicts IMR exacerbation and post-pPCI heart failure, serving as a prognostic biomarker in STEMI.
Insights
Growth Differentiation Factor 11 (GDF11) levels predict worsening ischemic mitral regurgitation (IMR) and heart failure in ST-elevation myocardial infarction (STEMI) patients after percutaneous coronary intervention (pPCI). Higher GDF11 indicates a better prognosis.
Area of Science:
- Cardiology
- Biomarkers
- Regenerative Medicine
Background:
- Ischemic mitral regurgitation (IMR) is a frequent complication in ST-elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (pPCI).
- Growth Differentiation Factor 11 (GDF11), a known cardiovascular protective factor, has a potential role in modulating IMR progression and patient outcomes.
Purpose of the Study:
- To investigate the predictive value of serum GDF11 levels for IMR exacerbation and cardiac function post-pPCI in STEMI patients.
- To assess GDF11 as a prognostic biomarker for heart failure development in this patient cohort.
Main Methods:
- Serum GDF11 levels were measured pre-pPCI in 310 STEMI patients.
- Cox regression, ROC analysis, and Spearman's correlation were employed to analyze the association between GDF11, IMR progression, and cardiac function (including LVEF and left atrial dimensions).
Main Results:
- Lower serum GDF11 levels significantly predicted IMR worsening (HR=0.982, P=0.004) and were associated with reduced cardiac function.
- Higher GDF11 levels correlated with reduced IMR progression (P=0.0013) and lower risk of heart failure (P=0.0003).
- GDF11 levels showed significant correlation with LVEF and left atrial changes (P<0.05).
Conclusions:
- Serum GDF11 is an independent predictor of IMR exacerbation and post-pPCI heart failure in STEMI patients.
- GDF11 serves as a valuable prognostic biomarker for assessing cardiovascular outcomes in STEMI patients complicated by IMR.
More Related Videos
Related Concept Videos
Mitral Regurgitation I: Introduction
Mitral Regurgitation III: Medical Management
Mitral Regurgitation IV: Nursing Management
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Freezing Point Depression and Boiling Point Elevation
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
Correlations

